I suppose each product below is worth a lot of money if sold as sales ramp up , the pandemic has not helped , RHT @ $74 million market cap is a serious take over target from big pharma, patients would prefer a scan than a biopsy (knife ) RHT is transitioning from development to commercialisation and sales.
Speaking on Ajay’s appointment, Mitchell Wells, Managing Director of Resonance Health said: “We’ve started the process of scaling the Company for growth and we’re excited to welcome Ajay to Resonance Health. He has vast international experience in medicalsales and marketing and has worked throughout South-East Asia, China, and the United States, all core target growth areas for Resonance Health. Over the coming months we will be recruiting a global sales team and increasing our human resources as we continue to transition from development to commercialisation and sales.
” Commenting on his appointment, Ajay Nair said: “I’m tremendously excited for the opportunity to join such an amazing company at such a crucial time. I am inspired by the Company’s mission and its exciting pipeline of best-in-class medical diagnostic products and services. Additionally, Resonance Health's current vantage point of being 'launch ready' with several AI based and critically needed products with an eye towards global commercialisation perfectly fits the experience I bring.”
